Julia A. Gindele

Boehringer Ingelheim (Germany)

Papers

1

Total Citations

66

H-Index

1

About

Julia A. Gindele is a leading figure in respiratory biology and in vitro toxicology, whose work has advanced the development of physiologically relevant models for studying human airway disease. Her primary research focuses on creating miniaturized, high-throughput platforms that recapitulate the human small airway epithelium, enabling more accurate drug discovery and safety assessment. Gindele’s most notable contribution is the development of a miniaturized 96-Transwell air–liquid interface human small airway epithelial model, a breakthrough that addresses the critical challenge of limited cell availability from clinical samples. This system, which has garnered 66 citations, allows researchers to conduct respiratory assays with unprecedented efficiency, reducing the need for large cell numbers while maintaining complex tissue architecture and function. By bridging the gap between traditional cell culture and in vivo models, Gindele’s work has paved the way for scalable, cost-effective screening of inhaled therapeutics and environmental toxicants. Her achievements underscore a commitment to translational science, making her a key innovator in the quest for more predictive preclinical tools in pulmonary research.

Research Focus

Key Achievements

1
H-Index
1
Papers
66
Total Citations
66
Avg Citations/Paper
🏆 Most Cited Paper
Development of a miniaturized 96-Transwell air–liquid interface human small airway epithelial model
66 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Boehringer Ingelheim (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago